Year: 2024 | Month: January-March | Volume: 9 | Issue: 1 | Pages: 276-281
DOI: https://doi.org/10.52403/ijshr.20240137
Parathyroid Carcinoma: A Rare Endocrine Malignancy
Zineb Ait Si Ali1, Oussama Jaddi1, Sana Rafi1, Ghizlane El Mghari1, Nawal EL Ansari1
1Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition Cadi Ayyad University, Mohammed VI University Hospital, Marrakech, Morocco
Corresponding Author: Zineb Ait Si Ali
ABSTRACT
Introduction: Parathyroid carcinoma is a rare neoplasm that may present sporadically or in the context of a genetic syndrome. Diagnosis and management are challenging due to the lack of consensus on the optimal management strategy.
Case report: We report the case of a 51years old male, diagnosed initially with parathyroid carcinoma, and presented recurrence and lymph node involvement.
Conclusions: Parathyroid carcinoma is a very rare cancer, that continues to pose considerable challenges in terms of diagnosis and management. The aim of parathyroid carcinoma therapy is not only oncological, but also to achieve biochemical remission. Surgery is the gold standard treatment of this entity. Future prospective randomized studies are needed to assess the effects of different surgical approaches on morbidity, mortality and oncological outcomes.
Keywords: Parathyroid - Carcinoma - Hyperparathyroidism - Management - Prognosis.